AllianceBernstein (AB) Tops Q4 EPS by 27c

AllianceBernstein (NYSE: AB) reported Q4 EPS of $1.27, $0.27 better than the analyst estimate of $1.00. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $966.91 million.

For earnings history and earnings-related data on AllianceBernstein (AB) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance